Company intelligence / Profile preview
NxCare
Tokyo, Tokyo Prefecture, Japannxera.life ↗
- Ownership
- Private
- Employees
- ~350
- Development stage
- Other
01
Overview
Nxera Pharma has more than 30 active programs spanning from discovery through late clinical stages and commercialized products in Japan; pipeline focuses on major unmet needs in neurology, GI/immunology, metabolic, and rare diseases, leveraging its proprietary structure-based GPCR platform[1].
- Therapeutic areas
- Rare DiseasesMetabolic DisordersNeurologyGastroenterologyImmunology
- Modalities
- Small moleculeMonoclonal antibodyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Leading pharma and biotech companies (specifics not listed in results)[1]
Beyond the preview
Go deeper on NxCare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NxCare.